In contrast to CDK6, high expression of CDK4 in p185BCR-ABL+ leukemic cells did not increase p16INK4a expression, nor was any change in tumor growth observed (Figures S2E–S2H). The gene discussed is CDKN2A; the disease is neoplasm.